Symbol | Exchange | Currency |
|---|
Genedrive PLC (LON:GDR) said it is targeting the end of September or early October for obtaining a European CE marking for its Genedrive COV19-ID Kit. The company intends to launch...
What the company does genedrive PLC (LON:GDR) is a molecular diagnostics company developing and commercialising low cost and rapid molecular diagnostics platform for the diagnosis...
genedrive PLC (LON:GDR) shares surged on Friday after the diagnostics firm confirmed it has received a licence to import its COVID-19 testing kit into India through its partner...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Neutral | Sell | Strong Sell | Strong Sell |
| Technical Indicators | Strong Buy | Neutral | Sell | Strong Sell | Strong Sell |
| Summary | Strong Buy | Neutral | Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 165.36 | 174.00 | 164.72 | -10.36 | -5.90% | 12.45M | London | |||
| 8,725.00 | 8,728.00 | 8,609.00 | +26.0 | +0.30% | 584.78K | London | |||
| 274.11 | 274.35 | 269.95 | +4.61 | +1.71% | 2.35M | London | |||
| 2,594.00 | 2,594.00 | 2,572.50 | +10.5 | +0.41% | 808.15K | London | |||
| 8,076.00 | 8,082.00 | 7,944.00 | +154.0 | +1.94% | 216.14K | London | |||
| 201.54 | 211.60 | 198.00 | -4.00 | -1.95% | 9.87M | London | |||
| 0.83 | 0.00 | 0.00 | +0.12 | +17.24% | 60.07M | London | |||
| 41.00 | 41.00 | 41.00 | +5.50 | +15.71% | 3.47M | London | |||
| 2,815.00 | 2,870.50 | 2,804.50 | -11.0 | -0.39% | 1.71M | London | |||
| 397.20 | 397.20 | 393.50 | +3.70 | +0.94% | 7.94M | London | |||
| 338.65 | 349.98 | 335.00 | +15.65 | +4.85% | 49.67K | London | |||
| 869.00 | 949.00 | 860.40 | -53.00 | -5.75% | 4.66M | London | |||
| 285.10 | 285.50 | 285.10 | -0.20 | -0.07% | 5.06M | London | |||
| 2,166.11 | 2,211.00 | 2,059.00 | +43.00 | +2.02% | 1.35M | London | |||
| 233.60 | 233.90 | 232.20 | +0.40 | +0.17% | 7.84M | London |
Genedrive Plc is a United Kingdom-based holding company engaged in molecular diagnostics business. The Company provides a molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. Its geographical segments include the United Kingdom, Europe, the United States of America and Asia. Genedrive is a small polymerase chain reaction (PCR) platform, which enables nucleic acid amplification and detection from various sample types, including plasma, sputum and buccal swabs. Genedrive system includes Genedrive hepatitis C virus (HCV) ID Kit for detection of Hepatitis C, and Genedrive IL28B ID Kit for the detection of Interleukin 28B genotyping status.